Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Repayments (2018)

Historic Long-Term Debt Repayments for Aclaris Therapeutics (ACRS) over the last 1 years, with Q4 2018 value amounting to $149000.0.

  • Aclaris Therapeutics' Long-Term Debt Repayments changed N/A to $149000.0 in Q4 2018 from the same period last year, while for Dec 2021 it was $612000.0, marking a year-over-year change of. This contributed to the annual value of -$11.5 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Aclaris Therapeutics' Long-Term Debt Repayments is $149000.0.
  • Aclaris Therapeutics' 5-year Long-Term Debt Repayments high stood at $299000.0 for Q2 2018, and its period low was $36000.0 during Q1 2018.